PMA P030044S004
- Device
- EGFR pharmDx
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P030044
- Supplement
- S004
- Product code
- NQF
- Decision date
- 2018-01-22
- Classification
- Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
- Generic name
- Immunohistochemistry assay, antibody, epidermal growth factor receptor
- Approval order statement
- Changed manufacturing process (order of addition) of components in two diluent solutions.
Current openFDA PMA Record#
- Device
- EGFR pharmDx
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P030044
- Supplement
- S004
- Product code
- NQF
- Generic name
- Immunohistochemistry assay, antibody, epidermal growth factor receptor
- Decision date
- 2018-01-22
- Decision code
- OK30
- Date received
- 2017-12-26
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- Changed manufacturing process (order of addition) of components in two diluent solutions.